Market Access/ News/ News EC to update IP rules to benefit generic exports Linda Banks biosimilar, biosimilars Europe, EC, EU, European Commission, European pharma, generics, pharma IP, Pharma regulation 0 Comment The European Commission (EC) is proposing to adjust intellectual property (IP) rules to help Europe’s pharma companies tap into fast-growing global markets. Share X EC to update IP rules to benefit generic exports https://pharmaphorum.com/news/ec-update-ip-rules-generic-exports/
Articles/ Clinical/ Healthcare/ Sales and Marketing/ UK & Europe/ Views and analysis Clinical trial lay summaries: a clearer picture emerges Linda Banks clinical trial data, clinical trial lay summaries, clinical trials, EC, EU, lay summary, patient centricity, patients 0 Comment EC wants pharma to make clinical trial results more patient-friendly. Share X Clinical trial lay summaries: a clearer picture emerges https://pharmaphorum.com/views-and-analysis/clinical-trial-lay-summaries-clearer-picture-emerges/